home / stock / ew / ew articles

EW Articles, Edwards Lifesciences Corporation

Stock Information
Company Name: Edwards Lifesciences Corporation
Stock Symbol: EW
Market: NYSE
Website: edwards.com
Menu
EW EW Quote EW Short EW News EW Articles EW Message Board
Get EW Alerts

News, Short Squeeze, Breakout and More Instantly...
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today | Benzinga

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.86% on an annualized basis producing an average annual retu...
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today | Benzinga

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.47% on an annualized basis producing an average annual retu...

BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details | Benzinga

Shares of medical technology company Becton, Dickinson And Company (NYSE:BDX) are trading higher after the company said it will acquire Edwards Lif...

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today | Benzinga

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.47% on an annualized basis producing an average annual retu...
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint | Benzinga

On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competito...

Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy' | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer said the new product line of Edwards Lifesciences Corporation (NYSE:EW) is ̶...

$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today | Benzinga

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 8.25% on an annualized basis producing an average annual retur...
Strategic Sale: Catherine Szyman Decides To Exercise Options Worth $2.32M At Edwards Lifesciences | Benzinga

A significant insider transaction involving the exercise of company stock options was reported on February 15, by Catherine Szyman, CVP at Edwards ...

$100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today | Benzinga

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 11.27% on an annualized basis producing an average annual retu...

FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom | Benzinga

On Tuesday, February 13, 2024, the FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet regar...
Next 10